Osaka, Japan

Nobuhisa Fukuda

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Suita, JP (2014)
  • Osaka, JP (2009 - 2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Nobuhisa Fukuda: Innovator in Pharmaceutical Chemistry

Introduction

Nobuhisa Fukuda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of five patents to his name, Fukuda's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Fukuda's latest patents include a compound represented by the formula (1), which is an (cycloalkyl-carbonyl)proline derivative. This compound exhibits excellent FXIa inhibitory activity and is useful as a therapeutic agent against thrombosis. Another notable invention is the N-substituted-cyclic amino derivative, which provides a compound that serves as a renin inhibitor. These innovations highlight Fukuda's focus on developing effective pharmaceutical agents.

Career Highlights

Throughout his career, Nobuhisa Fukuda has worked with notable companies such as Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Fukuda has collaborated with esteemed colleagues, including Yohei Ikuma and Hiroyuki Nakahira. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Nobuhisa Fukuda's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to pave the way for advancements in therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…